Clinical research • Troy Media Digital Solutions

New drug to treat muscular dystrophy based on U of A research

The U.S. FDA has approved a drug called viltolarsen to treat Duchenne muscular dystrophy. The drug was developed based on research by U of A medical geneticist Toshifumi Yokota. (Photo: Supplied)

Reading Time: 3 minutes Created using synthetic DNA, viltolarsen is an excellent example of precision medicine

Antiviral drug remdesivir offers second mechanism of attack

Reading Time: 3 minutes Understanding how the conditionally approved COVID-19 drug works is key to improving treatments, says U of A researcher

Little evidence vitamin D prevents severe COVID-19

Reading Time: 3 minutes Getting too much vitamin D can also cause health problems, says U of A pediatric kidney specialist

Get science out of the lab and onto the street to save lives

Reading Time: 6 minutes We know good safety practices from our grandmother – but are we courageous and persistent enough to follow them?

Tag: Clinical research

New drug to treat muscular dystrophy based on U of A research

Antiviral drug remdesivir offers second mechanism of attack

Little evidence vitamin D prevents severe COVID-19

Get science out of the lab and onto the street to save lives

Pin It on Pinterest